Long-acting opioids and cardiovascular diseases: Help or hindrance!

被引:6
|
作者
Mehta, Ankita [1 ]
Patel, Bhoomika M. [2 ,3 ]
机构
[1] Labcorp Cent Lab Serv Ltd Partnership, Bangalore, India
[2] Natl Forensic Sci Univ, Gandhinagar, India
[3] Natl Forensic Sci Univ, Sect 9, Gandhinagar 382007, Gujarat, India
关键词
Cardiac opioid receptors; Long -acting opioids (LAO); Methadone; Buprenorphine; Naltrexone; QTC INTERVAL PROLONGATION; PEPTIDE GENE-EXPRESSION; BAROREFLEX-MEDIATED BRADYCARDIA; TORSADES-DE-POINTES; RECEPTOR STIMULATION; CARDIAC-ARREST; PREJUNCTIONAL MODULATION; VENTRICULAR-ARRHYTHMIAS; NOCICEPTIN/ORPHANIN FQ; MYOCARDIAL-ISCHEMIA;
D O I
10.1016/j.vph.2023.107144
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Opioids are widely being used for chronic pain management, cough and diarrhea suppressants, anesthetic agents, and opioid de-addiction therapy. Opioid receptors, present in the central nervous system and peripheral tissues, are documented to regulate several cardiac functions through different signaling pathways. Long-acting opioids (LAO) have been successfully evaluated for their beneficial effects in various cardiovascular diseases viz. myocardial infarction, ischemic reperfusion injuries, atherosclerosis etc. However, on the other hand, several research studies pointed towards the harmful effects of LAOs which are mainly associated with QTc prolongation, torsade de pointes, ventricular arrhythmias, and cardiac arrest. This review shall familiarize readers with the benefits as well as the harmful effects of long-acting opioids in cardiovascular diseases. We have also provided an overview of cardiac opioid receptors, endogenous cardiac opioid peptides, and regulation of cardiovascular functions by central and cardiac opioid receptors.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Quality assurance in the prescribing of patient-controlled analgesia and long-acting opioids
    Lutomski, DM
    Niemeyer, S
    Payne, C
    Pruemer, J
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (14) : 1476 - 1479
  • [43] Initiation of Long-Acting Opioids Following Hospital Discharge Among Medicare Beneficiaries
    Deshpande, Bhushan R.
    McCarthy, Ellen P.
    Jung, Yoojin
    Anderson, Timothy S.
    Herzig, Shoshana J.
    JOURNAL OF HOSPITAL MEDICINE, 2021, 16 (12) : 724 - 726
  • [44] Short-Acting Opioids Are Associated with Comparable Analgesia to Long-Acting Opioids in Patients with Chronic Osteoarthritis with a Reduced Opioid Equivalence Dosing
    Ghodke, Ameer
    Barquero, Stephanie
    Chelminski, Paul R.
    Ives, Timothy J.
    PAIN MEDICINE, 2018, 19 (11) : 2191 - 2195
  • [45] Long-acting opioids for refractory chronic migraine: patient selection and guidelines for use
    Robbins, L.
    CEPHALALGIA, 2009, 29 : 51 - 51
  • [46] Intrinsically long-acting agents compared with long-acting chronoformulations
    Meredith, PA
    BLOOD PRESSURE MONITORING, 2000, 5 : S25 - S30
  • [47] Association of Cardiovascular Outcomes and Mortality With Sustained Long-Acting Insulin Only vs Long-Acting Plus Short-Acting Insulin Treatment
    Schroeder, Emily B.
    Neugebauer, Romain
    Reynolds, Kristi
    Schmittdiel, Julie A.
    Loes, Linda
    Dyer, Wendy
    Pimentel, Noel
    Desai, Jay R.
    Vazquez-Benitez, Gabriela
    Ho, P. Michael
    Anderson, Jeffrey P.
    O'Connor, Patrick J.
    JAMA NETWORK OPEN, 2021, 4 (09)
  • [48] Use of long-acting, vs short-acting, opioids for chronic pain was linked to unintentional overdose
    Holbrook, Anne
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (02)
  • [49] Novel, Long-Acting Drug May Help Prevent and Treat Malaria
    Hampton, Tracy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (09): : 866 - 866
  • [50] Long-Acting Oral Drug Device May Help Combat Malaria
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (01): : 17 - 17